BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 11046061)

  • 1. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
    J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
    Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
    J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.
    Matsuo Y; Raimondo M; Woodward TA; Wallace MB; Gill KR; Tong Z; Burdick MD; Yang Z; Strieter RM; Hoffman RM; Guha S
    Int J Cancer; 2009 Sep; 125(5):1027-37. PubMed ID: 19431209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling.
    Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A
    Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways.
    Schraufstatter IU; Chung J; Burger M
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1094-103. PubMed ID: 11350788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
    Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
    FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2.
    Moldobaeva A; Wagner EM
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1117-23. PubMed ID: 15722378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
    Strieter RM; Polverini PJ; Kunkel SL; Arenberg DA; Burdick MD; Kasper J; Dzuiba J; Van Damme J; Walz A; Marriott D
    J Biol Chem; 1995 Nov; 270(45):27348-57. PubMed ID: 7592998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELR+-CXC chemokines and their receptors in early metanephric development.
    Levashova ZB; Sharma N; Timofeeva OA; Dome JS; Perantoni AO
    J Am Soc Nephrol; 2007 Aug; 18(8):2359-70. PubMed ID: 17634442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface heparan sulfate participates in CXCL1-induced signaling.
    Wang D; Sai J; Richmond A
    Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
    Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
    Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness).
    Hall LR; Diaconu E; Patel R; Pearlman E
    J Immunol; 2001 Mar; 166(6):4035-41. PubMed ID: 11238651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A.
    Scapini P; Morini M; Tecchio C; Minghelli S; Di Carlo E; Tanghetti E; Albini A; Lowell C; Berton G; Noonan DM; Cassatella MA
    J Immunol; 2004 Apr; 172(8):5034-40. PubMed ID: 15067085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist.
    Berg C; Wedemeyer MJ; Melynis M; Schlimgen RR; Hansen LH; Våbenø J; Peterson FC; Volkman BF; Rosenkilde MM; Lüttichau HR
    PLoS Pathog; 2022 Mar; 18(3):e1010355. PubMed ID: 35271688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
    Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
    Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
    Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
    Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokines in angiogenesis.
    Strieter RM; Burdick MD; Gomperts BN; Belperio JA; Keane MP
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):593-609. PubMed ID: 16046180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protective role for ELR+ chemokines during acute viral encephalomyelitis.
    Hosking MP; Liu L; Ransohoff RM; Lane TE
    PLoS Pathog; 2009 Nov; 5(11):e1000648. PubMed ID: 19893623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokines in angiogenesis relevant to chronic fibroproliferation.
    Strieter RM; Belperio JA; Burdick MD; Keane MP
    Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):23-6. PubMed ID: 15720231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.